Centessa Pharmaceuticals plc - ADR Stock
Centessa Pharmaceuticals plc - ADR Stock price
Key metrics
| Market capitalization | $1.73b |
| Enterprise Value | $1.37b |
| P/E (TTM) P/E ratio | negative |
| EV/FCF (TTM) EV/FCF | negative |
| P/B ratio (TTM) P/B ratio | 4.31 |
| Revenue growth (TTM) Revenue growth | -100.00% |
| Revenue (TTM) Revenue | $0.00 |
| EBIT (operating result TTM) EBIT | $-200.87m |
| Free Cash Flow (TTM) Free Cash Flow | $-142.15m |
Is Centessa Pharmaceuticals plc - ADR a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?
As a Free StocksGuide user, you can view scores for all 6,794 stocks worldwide.
Centessa Pharmaceuticals plc - ADR Stock Analysis
Analyst Opinions
10 Analysts have issued a Centessa Pharmaceuticals plc - ADR forecast:
Analyst Opinions
10 Analysts have issued a Centessa Pharmaceuticals plc - ADR forecast:
Financial data from Centessa Pharmaceuticals plc - ADR
| Dec '24 |
+/-
%
|
||
| Revenue | - - |
-
|
|
| Gross Profit | -0.94 -0.94 |
115%
115%
|
|
| EBITDA | -200 -200 |
17%
17%
|
EBIT (Operating Income) EBIT | -201 -201 |
17%
17%
|
| Net Profit | -235 -235 |
55%
55%
|
|
In millions USD.
Don't miss a Thing! We will send you all news about Centessa Pharmaceuticals plc - ADR directly to your mailbox free of charge.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Centessa Pharmaceuticals plc - ADR Stock News
Company Profile
Centessa Pharmaceuticals Ltd. operates as pharmaceutical company that develops medicines. The company was founded on October 26, 2020 and is headquartered in Cambridge, the United Kingdom.
| Head office | United Kingdom |
| CEO | Saurabh Saha |
| Employees | 77 |
| Founded | 2013 |
| Website | centessa.com |
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
